V. Gushchin

发表

Nuclear electric resonance and orientation of carrier spins by an electric field

V. A. Khablo, V. Baskov, V. Ganenko, 1989 .

Non-labeled selective virus detection with novel SERS-active porous silver nanofilms fabricated by Electron Beam Physical Vapor Deposition

A. Sarychev, V. Gushchin, I. Kurochkin, 2018 .

Geographical and Tick-Dependent Distribution of Flavi-Like Alongshan and Yanggou Tick Viruses in Russia

A. Shchetinin, V. Gushchin, V. Trifonov, 2021, Viruses.

Modulation of Endolysin LysECD7 Bactericidal Activity by Different Peptide Tag Fusion

E. V. Usachev, V. Gushchin, I. Grigoriev, 2020, Biomolecules.

Study of kinetics of epithelial cell populations in normal tissues of the rat's intestines and in carcinogenesis. I. A comparison of enterocyte population kinetics in different segments of the small intestine and colon.

V. Gushchin, K. M. Pozharisski, V. F. Klimashevski, 1980, Experimentelle Pathologie.

Study of kinetics of epithelial cell populations in normal tissues of the rat's intestines and in carcinogenesis. II. Peculiarities of kinetics of enterocyte populations in experimental tumours of the colon.

V. Gushchin, K. M. Pozharisski, V. F. Klimashevski, 1980, Experimentelle Pathologie.

Impact of Aerosol Dust on xMAP Multiplex Detection of Different Class Pathogens

V. Gushchin, A. Gintsburg, A. Tkachuk, 2017, Front. Microbiol..

Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020

Darren L. Smith, Evelien M. Adriaenssens, Gemma L. Kay, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Topical treatment of LdMNPV-infected gypsy moth caterpillars with 18 nucleotides long antisense fragment from LdMNPV IAP3 gene triggers higher levels of apoptosis in infected cells and mortality of the pest.

V. Gushchin, Y. Gninenko, V. Makarov, 2016 .

MDR and Pre-XDR Clinical Mycobacterium tuberculosis Beijing Strains: Assessment of Virulence and Host Cytokine Response in Mice Infectious Model

V. Gushchin, I. Vasilyeva, A. Tkachuk, 2021, Microorganisms.

Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance

E. D. Belyaeva, V. Gushchin, I. Grigoriev, 2022, Vaccines.

Antiviral Activity of N1,N3-Disubstituted Uracil Derivatives against SARS-CoV-2 Variants of Concern

V. Gushchin, A. Gintsburg, D. Logunov, 2022, International journal of molecular sciences.

Immunological memory as a basis for a wise vaccination strategy. A rationale for introducing a comprehensive seroepidemiological surveillance system in Russia

V. Gushchin, A. Gintsburg, A. Tkachuk, 2017 .

Resistance to peptidoglycan-degrading enzymes

V. Gushchin, A. Grishin, A. Karyagina, 2020, Critical reviews in microbiology.

Different evolutionary dynamics of hepatitis B virus genotypes A and D, and hepatitis D virus genotypes 1 and 2 in an endemic area of Yakutia, Russia

V. Gushchin, O. Isaeva, S. Sleptsova, 2022, BMC Infectious Diseases.

Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A

E. V. Usachev, V. Gushchin, A. Gintsburg, 2022, bioRxiv.

PHYSICAL AND CHEMICAL PROPERTIES OF RECOMBINANT KPP10 PHAGE LYSINS AND THEIR ANTIMICROBIAL ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA

V. Gushchin, A. Tkachuk, V. Makarov, 2018 .

Broad Bactericidal Activity of the Myoviridae Bacteriophage Lysins LysAm24, LysECD7, and LysSi3 against Gram-Negative ESKAPE Pathogens

E. V. Usachev, V. Gushchin, A. Gintsburg, 2019, Viruses.

Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2

V. Gushchin, S. Lummis, Y. Utkin, 2021, Cellular and Molecular Life Sciences.

Dynamics of SARS-CoV-2 Major Genetic Lineages in Moscow in the Context of Vaccine Prophylaxis

E. D. Belyaeva, V. Gushchin, A. Gintsburg, 2022, International journal of molecular sciences.

Isolation and Characterisation of Alongshan Virus in Russia

A. Shchetinin, V. Gushchin, L. Bell-Sakyi, 2019, bioRxiv.

Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus

E. D. Belyaeva, V. Gushchin, I. Grigoriev, 2022, Frontiers in Immunology.

Translation of the shallot virus X TGB3 gene depends on non-AUG initiation and leaky scanning.

V. Gushchin, S. Morozov, A. Solovyev, 2015, The Journal of general virology.

Experimental studies of the Σ, T, P polarization parameters and the γp→pπ0 reaction multipole analysis in the first resonance region

V. Gushchin, L. Kolesnikov, A. Rubashkin, 1983 .

Proton polarization in deuteron disintegration by linearly polarized photons and dibaryon resonances

V. Gushchin, L. Kolesnikov, A. Rubashkin, 1986 .

Polarization observablesΣ,Py,T1 in the reaction $$\vec \gamma d \to \vec pn$$ at photon energies between 200 and 600 MeV and dibaryon resonances

V. Ganenko, V. Gushchin, L. Kolesnikov, 1992 .

INVESTIGATION OF THE G AND H PARAMETERS FOR THE REACTION GAMMA P ---> N PI+ IN THE REGION OF THE FIRST PI N RESONANCE. (IN RUSSIAN)

V. Gushchin, L. Kolesnikov, A. Rubashkin, 1985 .

Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2

V. Gushchin, I. Babichenko, M. Pavlyukov, 2020, bioRxiv.

The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia

E. Nabieva, V. Gushchin, A. Samoilov, 2022, Virus evolution.

Microbiological Characteristics of Some Stations of Moscow Subway

A. Shchetinin, V. Gushchin, A. Gintsburg, 2022, Biology.

Full-genome analysis and pathogenicity of a genetically distinct Russian PRRSV-1 Tyu16 strain.

A. Shchetinin, V. Gushchin, A. Gulyukin, 2020, Veterinary microbiology.

First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment

V. Gushchin, A. Gintsburg, A. Tkachuk, 2019, Vaccines.

Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study

V. Gushchin, A. Gintsburg, S. Fitilev, 2020, Vaccines.

Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models

V. Gushchin, A. Gintsburg, A. Tkachuk, 2017, PloS one.

A PROTOCOL OF DEVELOPMENT OF A SCREENING ASSAY FOR EVALUATING IMMUNOLOGICAL MEMORY TO VACCINE-PREVENTABLE INFECTIONS: SIMULTANEOUS DETECTION OF ANTIBODIES TO MEASLES, MUMPS, RUBELLA AND HEPATITIS B

V. Gushchin, A. Tkachuk, D. Kleymenov, 2017 .

Silent HDV epidemics culminates in high levels of liver cirrhosis in endemic region despite 20 years of HBV vaccination

V. Gushchin, L. Ilchenko, T. Kozhanova, 2022, Journal of viral hepatitis.

Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant

V. Gushchin, O. Karpova, P. Ivanov, 2022, Frontiers in Microbiology.

Molecular Alliance of Lymantria dispar Multiple Nucleopolyhedrovirus and a Short Unmodified Antisense Oligonucleotide of Its Anti-Apoptotic IAP-3 Gene: A Novel Approach for Gypsy Moth Control

A. S. Zaitsev, V. Gushchin, O. Skorokhod, 2017, International journal of molecular sciences.

Efficacy of the Endolysin-Based Antibacterial Gel for Treatment of Anaerobic Infection Caused by Fusobacterium necrophorum

V. Gushchin, A. Tkachuk, D. Vasina, 2021, Antibiotics.

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

V. Gushchin, A. Gintsburg, D. Logunov, 2021, The Lancet.

Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation

R. Valenta, V. Gushchin, A. Nikonova, 2021, Allergy.

Beet yellows virus replicase and replicative compartments: parallels with other RNA viruses

V. Gushchin, S. Morozov, A. Solovyev, 2013, Front. Microbiol..

Guide RNA Design for CRISPR/Cas9-Mediated Potato Genome Editing

V. Gushchin, M. Taliansky, A. Khromov, 2018, Doklady Biochemistry and Biophysics.

A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels

V. Gushchin, A. Gintsburg, D. Logunov, 2021, Frontiers in Immunology.

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults

V. Gushchin, A. Gintsburg, D. Logunov, 2021, The Lancet Regional Health - Europe.

Geographic and Temporal Variability of Hepatitis E Virus Circulation in the Russian Federation

V. Gushchin, A. Tkachuk, O. Isaeva, 2022, Viruses.

SARS-CoV-2 Aerosol and Surface Contamination in Health Care Settings: The Moscow Pilot Study

A. Shchetinin, V. Gushchin, A. Gintsburg, 2021 .

A Strategy for the Rapid Development of a Safe Vibrio cholerae Candidate Vaccine Strain

V. Gushchin, D. Karpov, A. Tkachuk, 2021, International journal of molecular sciences.

Collection and Processing of Logging Residual and Firewood in a Felling Area

V. Gushchin, K. Mikhaylov, A. Tarakanov, 2016 .

Antibiofilm Activity of a Broad-Range Recombinant Endolysin LysECD7: In Vitro and In Vivo Study

V. Gushchin, A. Gintsburg, A. Tkachuk, 2020, Viruses.

Engineered Endolysin LysECD7-SMAP Reveals Antimicrobial Synergy with Antibiotics and Restores Sensitivity in Gram-negative Pathogens

V. Gushchin, I. Grigoriev, A. Tkachuk, 2022, Applied Biochemistry and Microbiology.

Discovering the Potentials of Four Phage Endolysins to Combat Gram-Negative Infections

E. V. Usachev, V. Gushchin, I. Grigoriev, 2021, Frontiers in Microbiology.

Geochemical Features of Two-Phase Hydrocarbon-Pool Formation in Northern West Siberia

V. Gushchin, A. V. Ryl’kov, 1987 .

Proof-of-Concept Study of Liposomes with a Set of SARS-CoV-2 Viral Peptidic T-Cell Epitopes as a Vaccine

V. Gushchin, A. Alekseeva, I. Boldyrev, 2022, Russian Journal of Bioorganic Chemistry.

A conserved region in the Closterovirus 1a polyprotein drives extensive remodeling of endoplasmic reticulum membranes and induces motile globules in Nicotiana benthamiana cells.

David G. Karlin, V. Gushchin, S. Morozov, 2017, Virology.

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants

A. Shchetinin, V. Gushchin, O. Voronina, 2021, Vaccines.

Dynamic localization of two tobamovirus ORF6 proteins involves distinct organellar compartments.

V. Gushchin, K. Wright, M. Taliansky, 2013, The Journal of general virology.

Photodisintegration of 6Li into 3He and 3H by linearly polarized photons

V. M. Khvastunov, V. Ganenko, V. Gushchin, 1989 .

Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level

V. Gushchin, A. Gintsburg, D. Logunov, 2022, Vaccines.

Features of the Humoral Response to Infection, Vaccination, and Revaccination during COVID-19

V. Gushchin, A. Karaulov, O. Borisova, 2022, Bulletin of Experimental Biology and Medicine.

Sputnik Light booster after Sputnik V vaccination induces robust neutralizing antibody response to B.1.1.529 (Omicron) SARS-CoV-2 variant

V. Gushchin, F. Izhaeva, A. Tukhvatulin, 2021, medRxiv.

The RING for gypsy moth control: Topical application of fragment of its nuclear polyhedrosis virus anti-apoptosis gene as insecticide.

A. S. Zaitsev, V. Gushchin, O. Skorokhod, 2016, Pesticide biochemistry and physiology.

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals

V. Gushchin, A. Antinori, A. Gintsburg, 2022, medRxiv.

Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance

V. Gushchin, A. Gintsburg, D. Logunov, 2022, Vaccines.

SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies

V. Gushchin, A. Siniavin, D. Mazurov, 2021, bioRxiv.

SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical case

D. Chudakov, A. Shchetinin, V. Gushchin, 2022, Human vaccines & immunotherapeutics.

Sputnik V protection from COVID-19 in people living with HIV under antiretroviral therapy

E. V. Tsyganova, V. Gushchin, A. Gintsburg, 2022, eClinicalMedicine.

Contamination of Hospital Surfaces with Bacterial Pathogens under the Current COVID-19 Outbreak

V. Gushchin, A. Gintsburg, A. Tkachuk, 2021, International journal of environmental research and public health.

Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against seven vaccine-preventable diseases.

V. Gushchin, A. Gintsburg, A. Tkachuk, 2022, Journal of immunological methods.

Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2

V. Gushchin, Y. Utkin, V. Tsetlin, 2021, Cellular and molecular life sciences : CMLS.

Snake venom phospholipases A2 possess a strong virucidal activity against SARS-CoV-2 in vitro and block the cell fusion mediated by spike glycoprotein interaction with the ACE2 receptor

V. Gushchin, Y. Utkin, V. Tsetlin, 2021, bioRxiv.

Arboviruses in the Astrakhan region of Russia for 2018 season: The development of multiplex PCR assays and analysis of mosquitoes, ticks, and human blood sera.

A. Shchetinin, V. Gushchin, A. Gintsburg, 2021, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Making sense of nuclear localization: A zinc-finger protein encoded by a cytoplasmically replicating plant RNA virus acts a transcription factor

V. Gushchin, E. Savenkov, A. Solovyev, 2013, Plant signaling & behavior.

Study of kinetics of epithelial cell populations in normal tissues of the rat's intestines and in carcinogenesis. III. Changes in kinetics of enterocyte populations in the course of experimental intestinal tumour induction in rats.

V. Gushchin, K. M. Pozharisski, V. F. Klimashevski, 1982, Experimental pathology.

Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination

V. Gushchin, A. Tkachuk, O. Isaeva, 2023, Vaccines.

An Open, Non-Randomised, 1/2 Phase Study on the Safety, Tolerability, and Immunogenicity of Single Dose 'Sputnik Light' Vaccine for Prevention of Coronavirus Infection in Healthy Adults

V. Gushchin, A. Gintsburg, D. Logunov, 2021, SSRN Electronic Journal.

Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study

V. Gushchin, A. Gintsburg, D. Logunov, 2023, Frontiers in immunology.